- Home
- MOS vs ALKS Comparison
MOS vs ALKS Comparison
Compare MOS & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MOS | ALKS |
|---|---|---|
| Founded | 1987 | 1987 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.3B | 8.7B |
| IPO Year | 2004 | 2012 |
Fundamental Metrics
Financial Performance| Metric | MOS | ALKS |
|---|---|---|
| Price | $25.20 | $45.90 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 16 | 14 |
| Target Price | $31.94 | ★ $43.43 |
| AVG Volume (30 Days) | ★ 7.0M | 1.2M |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.82% | N/A |
| EPS Growth | ★ 209.09 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,052,400,000.00 | $1,475,899,000.00 |
| Revenue This Year | $9.01 | $24.26 |
| Revenue Next Year | N/A | $4.47 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 8.36 | N/A |
| 52 Week Low | $19.80 | $26.40 |
| 52 Week High | $37.00 | $55.67 |
Technical Indicators
Market Signals| Indicator | MOS | ALKS |
|---|---|---|
| Relative Strength Index (RSI) | 60.95 | 37.28 |
| Support Level | $23.31 | $27.52 |
| Resistance Level | $25.83 | $51.25 |
| Average True Range (ATR) | 1.09 | 1.25 |
| MACD | 0.20 | -0.26 |
| Stochastic Oscillator | 63.05 | 26.46 |
Price Performance
Historical ComparisonAbout MOS Mosaic Company (The)
Mosaic is one of the largest phosphate and potash producers in the world. The company's assets include phosphate rock mines in the US and potash mines in Canada. Mosaic also runs a large fertilizer distribution operation in Brazil through its Mosaic Fertilizantes business.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.